Zobrazeno 1 - 10
of 529
pro vyhledávání: '"Yee Chao"'
Autor:
I-Cheng Lee, Yung-Ping Tsai, Yen-Cheng Lin, Ting-Chun Chen, Chia-Heng Yen, Nai-Chi Chiu, Hsuen-En Hwang, Chien-An Liu, Jia-Guan Huang, Rheun-Chuan Lee, Yee Chao, Shinn-Ying Ho, Yi-Hsiang Huang
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Automatic segmentation of hepatocellular carcinoma (HCC) on computed tomography (CT) scans is in urgent need to assist diagnosis and radiomics analysis. The aim of this study is to develop a deep learning based network to detect H
Externí odkaz:
https://doaj.org/article/a92c0700a21943ae84df10a7de856154
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Despite the utilization of immune checkpoint inhibitors (ICIs) in treating numerous types of cancers being approved, their efficacy in tumor control in the clinic is not satisfactory. Since adoptive cell therapy (ACT) can alter th
Externí odkaz:
https://doaj.org/article/38f0b792947040ed84789f39d8bf878b
Autor:
Chih‐Chieh Yen, Yi‐Hsin Yang, Hsiu‐Ying Ku, Huang‐Ming Hu, Su‐Shun Lo, Hung‐Chi Chang, Yee Chao, Jen‐Shi Chen, Hsiu‐Po Wang, Tsang‐En Wang, Li‐Yuan Bai, Ming‐Shiang Wu, Chia‐Jui Yen, Li‐Tzong Chen, Yan‐Shen Shan
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16906-16917 (2023)
Abstract Background Gastrectomy remains the curative option in gastric cancer. However, the growing concern that preoperative waiting jeopardizes survival has not been fully addressed. The present population‐based cohort study aimed to clarify the
Externí odkaz:
https://doaj.org/article/afd010633a3f46fc98458e76aa241873
Autor:
Chia-Chu Fu, Cheng-Yi Wei, Chi-Jen Chu, Pei-Chang Lee, Teh-Ia Huo, Yi-Hsiang Huang, Yee Chao, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 7, Pp 593-602 (2023)
Background: Alpha fetoprotein (AFP) is the most widely used tumor marker for hepatocellular carcinoma (HCC). Nevertheless, few studies have investigated the prognostic factors of HCC patients with normal serum AFP levels. Methods: We retrospectively
Externí odkaz:
https://doaj.org/article/edf8869eec864fc383441d4d0df6257b
Autor:
Cheng‐Yu Tang, Jen‐Fan Hang, Yi‐Ping Hung, Nai‐Chi Chiu, Jiun‐I Lai, Ming‐Huang Chen, Chun‐Yu Liu, Muh‐Hwa Yang, Yee Chao, Peter Mu‐Hsin Chang
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1090-1101 (2023)
Abstract Background The prognosis of unfavorable cancer of unknown primary is extremely poor. This is the first report to compared the treatment results between generations of CUP and examined prognostic factors. Methods This retrospective single‐c
Externí odkaz:
https://doaj.org/article/5083ae094eaf4db9974114e04122f49f
Autor:
Yu‐Mei Kang, Hitoshi Ishikawa, Taku Inaniwa, Yuma Iwai, Naruhiro Matsufuji, Goro Kasuya, Noriyuki Okonogi, Yu‐Ming Liu, Yee Chao, Masaru Wakatsuki, Hirohiko Tsujii, Hiroshi Tsuji
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1540-1551 (2023)
Abstract Background To evaluate the clinical relative biological effectiveness (RBE) of carbon‐ion radiotherapy (C‐ion RT) for prostate cancer. Methods The records of 262 patients with low‐risk prostate cancer (median age, 65 [47–80] years) t
Externí odkaz:
https://doaj.org/article/657a12567feb4079b501c0bdc886484e
Autor:
Yu-Yun Shao, Yin-Hsun Feng, Chia-Jui Yen, Tsai-Sheng Yang, Ying-Chun Shen, Yee Chao, Jen-Shi Chen, Ching-Yen Su, Wei-Jen Chen, Hwa-Lin Hsiang, Chih-Hung Hsu
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 12, Pp 2430-2437 (2022)
Background: The combination of bevacizumab and atezolizumab has been established as a standard first-line systemic treatment for unresectable hepatocellular carcinoma (HCC). We examined the treatment outcomes of patients in Taiwan who received the co
Externí odkaz:
https://doaj.org/article/b516aa283916436c9db4ed35dc672f2a
Autor:
Joshua Tobias, Sandra Högler, Martin Raigel, Diego Shih-Chieh Lin, Yee Chao, Lukas Kenner, Erika Garner-Spitzer, Sharon Yavrom, Nicholas J. Ede, Christoph C. Zielinski, Michael Kundi, Ursula Wiedermann
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 287 (2023)
Her-2/neu-targeting therapy by passive application with trastuzumab is associated with acquired resistance and subsequent metastasis development, which is attributed to the upregulation of tumoral PD-L1 expression and the downregulation of Her-2/neu.
Externí odkaz:
https://doaj.org/article/bec8d8a4bc6f4924bd71e225660cc70c
Autor:
Chun-Yang Lee, Gar-Yang Chau, Cheng-Yi Wei, Yee Chao, Yi-Hsiang Huang, Teh-Ia Huo, Ming-Chih Hou, Yu-Hui Su, Jaw-Ching Wu, Chien-Wei Su
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We investigated the outcomes of patients with ruptured hepatocellular carcinoma (HCC) and identified the optimal treatment modality for such patients. We retrospectively enrolled 91 patients with treatment-naive HCC and tumor rupture at diag
Externí odkaz:
https://doaj.org/article/e831e7417d424e70aebcc8468c272c0e
Autor:
Philippe Merle, Masatoshi Kudo, Julien Edeline, Mohamed Bouattour, Ann-Lii Cheng, Stephen Lam Chan, Thomas Yau, Marcelo Garrido, Jennifer Knox, Bruno Daniele, Valeriy Breder, Ho Yeong Lim, Sadahisa Ogasawara, Stéphane Cattan, Yee Chao, Abby B. Siegel, Iván Martinez-Forero, Ziwen Wei, Chih-Chin Liu, Richard S. Finn
Publikováno v:
Liver Cancer (2023)
Introduction: KEYNOTE-240 showed a favorable benefit/risk profile for pembrolizumab versus placebo in patients with sorafenib-treated advanced hepatocellular carcinoma (HCC); however, prespecified statistical significance criteria for overall surviva
Externí odkaz:
https://doaj.org/article/cd768b0d783a455fbb086706dc35b886